Solventum Earnings
NYSE: SOLVHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 3:35 PM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$1.35
Solventum earnings summary
Solventum is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $1.35. In its most recent report on Aug 5, 2026 (Q2 2026), SOLV posted EPS of $0.53. Revenue for the quarter was $2.21 billion.
Quarterly EPS is up 3.9% from the same quarter a year earlier. Across the last 10 reports, SOLV shares moved an average of 4.2% (in either direction) in the first trading session after results, rising 4 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
SOLV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.53 | — | +6.8% |
| May 5, 2026 | — | $0.07 | — | +1.2% |
| Feb 27, 2026 | — | $0.37 | — | -6.5% |
| Nov 6, 2025 | — | $7.22 | — | +5.8% |
| Aug 8, 2025 | — | $0.51 | — | -2.7% |
| May 9, 2025 | — | $0.78 | — | +5.5% |
| Feb 28, 2025 | — | $0.18 | — | -2.3% |
| Nov 8, 2024 | — | $0.70 | — | -6.8% |
| Aug 9, 2024 | — | $0.51 | — | -2.0% |
| May 10, 2024 | — | $1.37 | — | -2.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.